Enliven Therapeutics ELVN
NASDAQ ELVN
$41.52 -0.41 (-0.98%)
At close: Oct 23, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Sale and Maturity of Investments (2020 - 2026)

Updated

Analysis

Enliven Therapeutics (ELVN) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Enliven Therapeutics 3.04 Bn 753.67 Mn - 118.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118.69 Mn
Mar 31, 2026 108.36 Mn
Dec 31, 2025 87.69 Mn
Sep 30, 2025 67.80 Mn
Jun 30, 2025 56.74 Mn
Mar 31, 2025 60.67 Mn
Dec 31, 2024 117.24 Mn
Sep 30, 2024 80.59 Mn
Jun 30, 2024 77.17 Mn
Mar 31, 2024 38.91 Mn
Dec 31, 2023 80.00 Mn
Sep 30, 2023 40.00 Mn
Sep 30, 2022 -11.95 Mn
Jun 30, 2022 6.48 Mn
Mar 31, 2022 5.47 Mn
Dec 31, 2021 3.30 Mn
Sep 30, 2021 13.40 Mn
Jun 30, 2021 7.20 Mn
Mar 31, 2021 22.04 Mn
Dec 31, 2020 29.60 Mn
API Access

Enliven Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ELVN&period=max&api_key=YOUR_API_KEY